Drug use and aplastic anaemia: The French experience

European Journal of Haematology, Supplement

Volumn 57, Issue 60, 1996, Pages 35-41

  Mary, Jean Yves ^a   Guiguet, Marguerite ^a   Baumelou, Elizabeth ^a  

^a INSERM   (France)

Author keywords

Aplastic anaemia; Case control; Drug related; France

Indexed keywords

ALLOTHIOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHYROID AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORAMPHENICOL; COLCHICINE; CORTICOSTEROID; DIURETIC AGENT; GOLD SALT; HORMONE; MEPROBAMATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PENICILLAMINE; QUINIDINE; QUININE; SALICYLIC ACID; SULFONAMIDE; TICLOPIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; APLASTIC ANEMIA; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FRANCE; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; ARTICLE; CHEMICALLY INDUCED DISORDER; INCIDENCE; PREVALENCE; REGISTER;

ANEMIA, APLASTIC; CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; PREVALENCE; REGISTRIES;

EID: 0030329645     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. AOKI K, FUJIKI N, SHIMIZU H, OHNO Y. Geographic and ethnic differences of aplastic anemias in humans. In: NAJEAN Y, ed. Medullary Aplasia. New York: Masson, 1980: 79-88.
2. SMICK KM, CONDIT PK, PROCTOR RL, SUTCHER V. Fatal aplastic anemia: an epidemiological study of its relationship to the drug chloramphenicol. J Chron Dis 1984: 17: 899-914.
3. WALLERSTEIN RO, CONDIT PK, KASPER CK, BROWN JW, MORRISON FR. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969: 208: 2045-2050.
4. MARY JY, BAUMELOU E, GUIGUET M, AND THE FRENCH COOPERATIVE GROUP FOR EPIDEMIOLOGICAL STUDY OF APLASTIC ANAEMIA. Epidemiology of aplastic anemia in France : a prospective multicentric study. Blood 1990: 75: 1646-1653.
5. CAMITTA BM, THOMAS ED, NATHAN DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979: 53: 504-514.
6. BOTTIGER LE, BOTTIGER B. Incidence and cause of aplastic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand 1981: 210: 475-479.
7. WILLIAMS DM, LYNCH RE, CARTWRIGHT GE. Drug induced aplastic anemia. Semin Haemal 1973: 10: 195-223.
8. ALTER BP, POTTER NU, LI FP. Classification and aetiology of the aplastic anemias. Clin Haematol 1978: 7: 431-465.
9. WEST BC, DEVAULT GA, JR, CLEMENT JC, WILLIAMS DM. Aplastic anemia with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. Rev Inf Dis 1988: 10: 1048-1051.
10. SMICK KM, CONDIT PK, PROCTOR RL, SUTCHER V. Fatal aplastic anemia. An epidemiological study of its relationship to the drug chloramphenicol. J Chron Dis 1964: 17: 899-914.
11. WALLERSTEIN RO, CONDIT PK, KASPER CK, BROWN JW, MORRISON FR. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969: 208: 2045-2050.
12. YUNIS AA. Chloramphenicol induced bone marrow suppression. Semin Haemat 1973: 10: 225-234.
13. BAUMELOU E, NAJEAN Y. Why still prescribe chloramphenicol in 1983? Blut 1983: 47: 317-320.
14. HEIMPEL H, HEIT W. Drug induced aplastic anemia: clinical aspect. Clin Haemat 1980: 9: 641-662.
15. VINCENT PC. Drug-induced aplastic anemia and agranulocytosis. Incidence and mechanisms. Drugs 1986: 31: 52-63.
16. BRIEF RS, LYNCH J, BERNATH T, SCALA RA. Benzene in the workplace. Am Ind Hyg Assoc 1980: 41: 616-623.
17. LEWIS EB. Leukemia, multiple myeloma and aplastic anemia in American radiologists. Science 1963: 142: 1492-1494.
18. BAUMELOU E, GUIGUET M, MARY JY AND THE FRENCH COOPERATIVE GROUP FOR EPIDEMIOLOGICAL STUDY OF APLASTIC ANAEMIA. Epidemiology of aplastic anemia in France: a case-control study. I: Medical history and medication use. Blood 1993: 81: 1471-1478.
19. GUIGUET M, BAUMELOU E, MARY JY AND THE FRENCH COOPERATIVE GROUP FOR EPIDEMIOLOGICAL STUDY OF APLASTIC ANAEMIA. A case-control study of aplastic anemia. II. Occupational exposures. Int J Epidemiol 1995: 24: 993-999.
20. BRESLOW NE, DAY NE. Statistical methods in cancer research. Vol I: The analysis of case-control studies. Lyon: IARC, 1980.
21. KLEINBAUM DG, KUPPER LL, MORGENSTERN H. Epidemiologic research. New York: Van Nostrand Reinhold Company, 1982.
22. BRESLOW NE, DAY NE. Statistical methods in cancer research. Vol II: The design and analysis of cohort studies. Lyon: IARC, 1987.
23. BESAMUSCA FW, BASTIAENSEN LA. Blood dyscrasias and topically applied chloramphenicol in ophthalmology. Doc Ophthalmol 1986: 64: 87-95.
24. SYNDICAT NATIONAL DE L'INDUSTRIE PHARMACEUTIQUE. Rapport du groupe de réflexion sur l'utilisation des hypnotiques et tranquillisants en France. Paris: Editions du SNIP, 1990.
25. INTERNATIONAL AGRANULOCYTOSIS AND APLASTIC ANEMIA STUDY. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 1983: 24: 833-836.
26. KRAMER MS, LANE DA, HUTCHINSON TA. Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the international agranulocytosis and aplastic anemia study. J Chron Dis 1987: 40: 1073-1085.
27. YOUNG NS, ALTER BP. Aplastic anemia acquired and inherited. Philadelphia: WB Saunders, 1994.
28. LINET MS, MARKOWITZ JA, SENSENBRENNER LL, et al. A case-control study of aplastic anemia. Leuk Res 1989: 13: 3-11.
29. ISSARAGRISIL SR FOR THE THAI APLASTIC ANEMIA STUDY GROUP. Preliminary results on epidemiology of aplastic anemia in Thailand. In: GLUCKMAN E, COULOMBEL L, eds. Ontogeny of Hematopoiesis: Aplastic Anemia. Vol 235. Paris: Editions INSERM/John Libbey Eurotext Ltd., 1995: 281-290.
30. KAUFMAN DW, KELLY JP, LEVY M, SHAPIRO S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press, 1991.
31. INTERNATIONAL AGRANULOCYTOSIS AND APLASTIC ANEMIA STUDY. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986: 256: 1749-1757.
32. KELLY JP, KAUFMAN DW, SHAPIRO S. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther 1991: 49: 330-341.
33. INTERNATIONAL AGRANULOCYTOSIS AND APLASTIC ANEMIA STUDY. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. Arch Intern Med 1989: 149: 1036-1040.
34. INTERNATIONAL AGRANULOCYTOSIS AND APLASTIC ANEMIA STUDY. Risk of agranulocytosis and aplastic anemia in relation to use of antithyroid drugs. Br Med J 1988: 297: 262-265.